Stock Market

Buy Cipla, target price Rs 685: Elara Capital

Cipla’s recent inhaler approval of generic of Proventil from the USFDA would aid in strong earnings visibility in the near term.

from Markets-Economic Times https://ift.tt/2xaxGWg

1 comment:

Powered by Blogger.